Western Wealth Management LLC Increases Position in HCA Healthcare, Inc. $HCA

Western Wealth Management LLC lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,633 shares of the company’s stock after purchasing an additional 179 shares during the quarter. Western Wealth Management LLC’s holdings in HCA Healthcare were worth $1,392,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in HCA. Brighton Jones LLC purchased a new position in shares of HCA Healthcare in the 4th quarter valued at about $1,021,000. Migdal Insurance & Financial Holdings Ltd. boosted its position in shares of HCA Healthcare by 75.8% in the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company’s stock worth $40,000 after acquiring an additional 50 shares during the last quarter. Diversify Advisory Services LLC acquired a new stake in HCA Healthcare during the 1st quarter valued at $280,000. Private Advisor Group LLC increased its stake in shares of HCA Healthcare by 82.0% in the first quarter. Private Advisor Group LLC now owns 7,926 shares of the company’s stock worth $2,739,000 after buying an additional 3,572 shares during the last quarter. Finally, Kestra Private Wealth Services LLC increased its position in shares of HCA Healthcare by 12.6% in the 1st quarter. Kestra Private Wealth Services LLC now owns 2,576 shares of the company’s stock worth $890,000 after purchasing an additional 288 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 0.4%

HCA opened at $474.52 on Monday. The firm has a market cap of $108.28 billion, a PE ratio of 18.34, a P/E/G ratio of 1.38 and a beta of 1.41. The business has a fifty day simple moving average of $433.56 and a 200-day simple moving average of $396.81. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $480.00.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the previous year, the firm earned $4.90 earnings per share. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of research analyst reports. Jefferies Financial Group increased their target price on HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a report on Tuesday, October 28th. The Goldman Sachs Group raised their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Barclays raised their target price on shares of HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Truist Financial boosted their price objective on HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Finally, Raymond James Financial set a $525.00 price target on shares of HCA Healthcare in a report on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $474.53.

Insider Activity

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.